Key facts
- Notable investors include Antler.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for M3TRIQ
- ·The full record, as it builds
Funding rounds
No funding rounds for M3TRIQ are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About M3TRIQ
Developer of an AI-generated biomolecule platform designed for optimizing cell culture and biomanufacturing processes. The company's platform automates ligand design, simulates biological outcomes, integrates regulatory filters, and optimizes formulations using reinforcement learning, enabling biotech and biomanufacturing sectors to cut costs, accelerate R&D, and ease regulatory pathways.
- Sector
- Healthcare
- HQ
- Kuala Lumpur, Malaysia
- Founded
- 2025
- Employees
- 2
- Website
- m3triq.com/
- Ownership
- Privately Held (backing)
M3TRIQ doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in M3TRIQ shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on M3TRIQ in its N-PORT filings yet. We sweep new filings monthly.